Results 141 to 150 of about 5,659 (182)

Cimetidine for erythropoietic protoporphyria

open access: yesPhotodiagnosis and Photodynamic Therapy, 2022
Erythropoietic protoporphyria (EPP) is caused by deficiency of the enzyme converting protoporphyrin IX (PpIX) into heme resulting in accumulation of PpIX; leading to photosensitivity and liver toxicity. Cimetidine might inhibit δ-aminolevulinic acid synthase influencing the heme biosynthesis.
Ida M Heerfordt, Catharina M Lerche
exaly   +6 more sources

Molecular epidemiology of erythropoietic protoporphyria in the U.K.

open access: yesBritish Journal of Dermatology, 2010
Background: Erythropoietic protoporphyria (EPP) is a cutaneous porphyria caused by mutations in the ferrochelatase (FECH) or, less frequently, the delta-aminolaevulinate synthase 2 (ALAS2) gene.
M N Badminton, G H Elder, A V Anstey
exaly   +2 more sources

Erythropoietic Protoporphyria and Photohemolysis

JAMA, 1964
Erythropoietic protoporphyria is a relatively rare metabolic anomaly occurring in childhood and characterized by various types of cutaneous lesions on light-exposed areas. The lesions are a photosensitive response to an excess of protoporphyrin. Diagnosis can be established by demonstrating a quantitative increase in erythrocyte protoporphyrin levels ...
L C, HARBER, A S, FLEISCHER, R L, BAER
openaire   +2 more sources

Erythropoietic protoporphyria

Journal of Inherited Metabolic Disease, 1997
AbstractPartial deficiency of the last enzyme of haem biosynthesis, ferrochelatase, leads to a distinct syndrome of photosensitivity caused by overproduction of protoporphyrin by erythropoietic tissue. Erythropoietic protoporphyria has an indeterminate pattern of inheritance and may be complicated by fulminating liver disease. The recent development of
openaire   +2 more sources

Erythropoietic protoporphyria in a boy

Archives of Disease in Childhood, 2014
A 9-year-old boy was assessed after experiencing a 2-year history of swelling and burning sensations on the dorsal surface of both hands, his face and his nose. His symptoms developed from the age of 2 years, were always associated with exposure to sun or warm temperature and would last up to …
Paola Sabrina, Buonuomo   +6 more
openaire   +2 more sources

Erythropoietic protoporphyria.

British Journal of Dermatology, 1976
The terminal stages of erythropoietic protoporphyria are recorded. The observations are related to the site of the fundamental lesion and the nature of the biochemical defect. The possibly ominous prognosis in this usually mild condition is emphasized. Apart from congenital porphyria, the porphyrias do not usually confer severe cutaneous lesions. These
D M, Macdonald, D C, Nicholson
openaire   +2 more sources

Erythropoietic protoporphyria

British Journal of Dermatology, 1994
Erythropoietic protoporphyria (EPP) is an inherited inborn error of porphyrin metabolism caused by decreased activity of the enzyme ferrochelatase, the terminal enzyme of the haem biosynthetic pathway, which catalyses the insertion of iron into protoporphyrin to form haem.
openaire   +2 more sources

Pseudoainhum and erythropoietic protoporphyria

British Journal of Dermatology, 1988
We report the development of pseudoainhum in a patient with erythropoietic protoporphyria, the first report, to our knowledge, of these two unusual conditions occurring together. An excellent cosmetic and functional result was achieved with a Z plasty.
A P, Christopher   +2 more
openaire   +2 more sources

Erythropoietic Protoporphyria

Journal of Cutaneous Medicine and Surgery, 2021
Ze-Hu Liu, Hong Shen
openaire   +2 more sources

Erythropoietic Protoporphyria

Archives of Dermatology, 1966
Abnormal in vitro red cell photohemolysis can be used as a diagnostic aid for erythropoietic protoporphyria. Photohemolysis is regularly present in erythropoietic protoporphyria and is negligible in normal subjects, in patients with polymorphic light eruption, and in lead poisoning.
openaire   +1 more source

Home - About - Disclaimer - Privacy